Skip to content

GILD

Gilead Sciences, Inc.

Revenue by product

2025, ended Dec 31, 2025

Earlier:

Products by fiscal year

Products by fiscal year
Line, in USD202520242023202220212020201920182017201620152014
Royalty, contract and other revenues527M144M182M299M297M334M330M450M445M437M——
Oncology3.24B—2.93B—————————
Cell Therapy
1.84B—1.87B—————————
28.1B27.7B26.1B26.0B26.2B23.6B21.5B21.0B24.1B25.4B31.8B24.1B
Total29.4B28.8B27.1B27.3B27.3B24.7B22.4B22.1B26.1B30.4B32.2B24.5B